Two women start the same hormone therapy in the same month. Same oral estradiol and dydrogesterone, same dose, same instructions. Four weeks later one of them says she feels like herself again. The other is still waiting, still counting hot flashes, still awake at three in the morning, and starting to wonder whether the problem is her.
If you are the second woman, this post is for you. A study published in Nature Medicine on November 3, 2026 looked at exactly that gap, and what it found had nothing to do with willpower, compliance or how badly anyone wanted the therapy to work.
What the study did
Chen and colleagues followed 356 perimenopausal women taking oral estradiol and dydrogesterone for six months. They measured neuroendocrine markers, metabolic markers and symptoms, and they sequenced the gut microbiome before and during therapy. On the whole the therapy did what it is meant to do: the neuroendocrine, metabolic and symptom outcomes improved.
The part that matters for the second woman is what happened to the gut. The therapy produced minimal gut changes. Six months of hormone therapy did not reshape the microbiome in any meaningful way. That alone is worth knowing, because a lot of what you read online says the opposite.
Where the difference came from
Response varied by the gut community each woman started with. The researchers grouped the women by their dominant baseline gut type. Women whose gut was dominated by a bacterium called Phocaeicola vulgatus showed greater hormonal responsiveness, superior clinical outcomes, and were more likely to reach what the authors call rapid clinical remission at four weeks. Women whose gut was dominated by Prevotella copri were less likely to get there that fast.
Read that direction carefully, because it is easy to get backwards. The therapy did not change the gut. The gut each woman started with tracked with her response to the therapy. The ground the prescription landed on was different, and nobody had looked at the ground.
What the study cannot tell you
The abstract describes no placebo group, so the study cannot separate the therapy's effect from time, attention or expectation. It was conducted at hospitals in China, and gut community types vary by region and diet, so the specific bacteria named here may not be the ones that matter in a different population. It is an association: the starting gut type tracked with response. It does not prove the gut caused the response, and it does not show that changing the gut would change the response.
Two more things it is not. It is not advice for or against hormone therapy. Whether to start, continue, adjust or stop sits with you and your prescriber, and nothing in this post should move that decision. And community typing of the kind used in this study is research, not a test you can order. No stool panel on the market, including ours, predicts how a woman will respond to hormone therapy, and anyone who tells you otherwise is ahead of the evidence.
Why this matters for the symptoms you have been calling normal
Here is the practical point. Perimenopause tends to arrive as a bundle: the hot flashes get the appointment, and the rest of the bundle gets filed under normal. The afternoon crash. The bloating that started around the same time. The joint stiffness in the morning. The 3 a.m. wake-up that is now just how you sleep. The fifteen-minute visit is built to treat the symptom that booked it, and the bundle goes home untouched.
A study like this one is a reason to stop treating that bundle as four unrelated problems. The gut is the foundation the rest of your health sits on, and in these 356 women it was part of the picture of how a hormone therapy landed. That does not mean the gut explains everything. It means it belongs in the conversation, and in most conversations it is not there.
How to read a study like this without overreaching
There are two ways to get this study wrong, and both are common online. The first is to read it as "your gut controls your hormones," which is not what it found; the therapy barely touched the gut, and the paper reports an association between a starting gut type and a clinical response, not a mechanism. The second is to dismiss it because it had no placebo group. The lack of a placebo arm limits what it can say about the therapy's own effect, but the comparison that matters here is between two groups of women on the same therapy, and that comparison stands on its own terms.
The honest reading sits in the middle. Three hundred and fifty-six women is a reasonable size for a microbiome study of this kind. Six months is long enough for a clinical response to show. And the finding that the starting gut community tracked with the speed of response is consistent with a broader pattern in the literature, in which the microbiome keeps turning up as a modifier of how people respond to medicines, from immunotherapy to metformin. That pattern is not proof. It is a reason to keep asking.
What this looks like in a real week
Picture the second woman again. She has been on therapy for ten weeks. The hot flashes are a little better; the sleep and the brain fog are not. At her follow-up she has nine minutes, and she spends most of them on the hot flashes because that is what the therapy was prescribed for. The 3 a.m. wake-ups come up as an aside. The bloating she has had since her late thirties does not come up at all; it was never on the list.
Nothing in that visit was wrong. It was just narrow, and the narrowness is built into the system, not into her or her prescriber. The study above is a reason to widen the frame before the next one: to walk in with the whole bundle written down, to ask what else could be slowing a response, and to treat the gut as part of the picture rather than a separate complaint for a separate specialist.
What to do this week
Four questions worth asking your prescriber at the next visit: what timeline did you expect for my symptoms, and when would you adjust; which symptoms are you tracking and which should I track; what else in my picture could slow a response; and what should I not change on my own.
And one thing to plan for before Thursday. Thanksgiving is the meal that sets a lot of women back a week: the bloat, the broken sleep, the hot flashes that come back, and the gut is in the middle of all of it. If the ground a therapy lands on matters, one meal that flattens that ground for a week is worth planning around. So this week the thing I am handing you is the Thanksgiving Swap Guide: fifteen classics swapped (turkey and gravy, stuffing, the pies, the drinks), six recipes that are low-inflammatory, low-histamine and AIP-friendly as written, and the twelve day-of tips we walk clients through every year. On the page you can tap a plan and see only the swaps that fit it, or download the PDF.
The guide is free at https://thehealthplex.co/thanksgiving. If you would rather talk your picture through with someone, the Clarity Call is free: https://call.thehealthplex.co
Source: Chen C, et al. Nature Medicine, 3 November 2026. https://doi.org/10.1038/s41591-026-04737-4 (PubMed abstract; full text not opened). Educational content, not medical advice. Everyone is unique and nothing here is a promised result.
—